|
| 37351909 | Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization. | Cancer Epidemiol Biomarkers Prev | 2023 |
| 36379355 | A Clinician's Guide to Bioinformatics for Next-Generation Sequencing. | J Thorac Oncol | 2023 |
| 36709663 | Results of TRIO-15, a multicenter, open-label, phase II study of the efficacy and safety of ganitumab in patients with recurrent platinum-sensitive ovarian cancer. | Gynecol Oncol | 2023 |
| 36639731 | Diagnostic and prognostic potential of the microbiome in ovarian cancer treatment response. | Sci Rep | 2023 |
| 37193618 | Artificial intelligence assisted whole organ pancreatic fat estimation on magnetic resonance imaging and correlation with pancreas attenuation on computed tomography. | | 2023 |
| 34810199 | Repurposing Ceritinib Induces DNA Damage and Enhances PARP Inhibitor Responses in High-Grade Serous Ovarian Carcinoma. | Cancer Res | 2022 |
| 35646902 | Nuclear GSK-3β and Oncogenic KRas Lead to the Retention of Pancreatic Ductal Progenitor Cells Phenotypically Similar to Those Seen in IPMN. | Front Cell Dev Biol | 2022 |
| 36256477 | Culture media composition influences patient-derived organoid ability to predict therapeutic responses in gastrointestinal cancers. | JCI Insight | 2022 |
| 35472731 | Machine-learning aided in situ drug sensitivity screening predicts treatment outcomes in ovarian PDX tumors. | Transl Oncol | 2022 |
| 34782396 | Influence of Cancer Susceptibility Gene Mutations and ABO Blood Group of Pancreatic Cancer Probands on Concomitant Risk to First-Degree Relatives. | Cancer Epidemiol Biomarkers Prev | 2022 |
| 34885153 | CHFR and Paclitaxel Sensitivity of Ovarian Cancer. | Cancers (Basel) | 2021 |
| 33545385 | Biomarker Discovery and Validation: Statistical Considerations. | Journal of Thoracic Oncology | 2021 |
| 33850213 | Statistical analysis of comparative tumor growth repeated measures experiments in the ovarian cancer patient derived xenograft (PDX) setting. | Sci Rep | 2021 |
| 33574088 | Smoking Modifies Pancreatic Cancer Risk Loci on 2q21.3. | Cancer Res | 2021 |
| 34107029 | Experimental design of preclinical experiments: number of PDX lines vs subsampling within PDX lines. | Neuro-Oncology | 2021 |
| 34258619 | Hepcidin-regulating iron metabolism genes and pancreatic ductal adenocarcinoma: a pathway analysis of genome-wide association studies. | Am J Clin Nutr | 2021 |
| 34082797 | Group III phospholipase A2 downregulation attenuated survival and metastasis in ovarian cancer and promotes chemo-sensitization. | Journal of Experimental and Clinical Cancer Research | 2021 |
| 33187969 | Shorter Treatment-Naïve Leukocyte Telomere Length is Associated with Poorer Overall Survival of Patients with Pancreatic Ductal Adenocarcinoma. | Cancer Epidemiol Biomarkers Prev | 2021 |
| 33342620 | Co-expression patterns of chimeric antigen receptor (CAR)-T cell target antigens in primary and recurrent ovarian cancer. | Gynecol Oncol | 2021 |
| 33067248 | THBS2/CA19-9 Detecting Pancreatic Ductal Adenocarcinoma at Diagnosis Underperforms in Prediagnostic Detection: Implications for Biomarker Advancement. | Cancer Prev Res (Phila) | 2021 |
| 35028612 | Multiomic analysis identifies CPT1A as a potential therapeutic target in platinum-refractory, high-grade serous ovarian cancer. | Cell Rep Med | 2021 |
| 32967863 | Mendelian Randomization Analysis of n-6 Polyunsaturated Fatty Acid Levels and Pancreatic Cancer Risk. | Cancer Epidemiol Biomarkers Prev | 2020 |
| 32312758 | Leukocyte Telomere Length and Its Interaction with Germline Variation in Telomere-Related Genes in Relation to Pancreatic Adenocarcinoma Risk. | Cancer Epidemiol Biomarkers Prev | 2020 |
| 32060098 | The DNA Cytosine Deaminase APOBEC3B is a Molecular Determinant of Platinum Responsiveness in Clear Cell Ovarian Cancer. | Clin Cancer Res | 2020 |
| 31714594 | Poly(adenosine diphosphate ribose) polymerase inhibitors induce autophagy-mediated drug resistance in ovarian cancer cells, xenografts, and patient-derived xenograft models. | Cancer | 2020 |
| 33154747 | Polymorphisms in STING Affect Human Innate Immune Responses to Poxviruses. | Front Immunol | 2020 |
| 32641412 | Genome-Wide Association Study Data Reveal Genetic Susceptibility to Chronic Inflammatory Intestinal Diseases and Pancreatic Ductal Adenocarcinoma Risk. | Cancer Res | 2020 |
| 32867043 | Challenges and Opportunities in Clinical Applications of Blood-Based Proteomics in Cancer. | Cancers | 2020 |
| 31103340 | Serum Proteomics on the Basis of Discovery of Predictive Biomarkers of Response to Androgen Deprivation Therapy in Advanced Prostate Cancer. | | 2019 |
| 31619387 | BRCA1 Deficiency Upregulates NNMT, Which Reprograms Metabolism and Sensitizes Ovarian Cancer Cells to Mitochondrial Metabolic Targeting Agents. | Cancer Res | 2019 |
| 31751381 | Overcoming platinum resistance in ovarian cancer by targeting pregnancy-associated plasma protein-A. | PLoS One | 2019 |
| 31604914 | ZC3H18 specifically binds and activates the BRCA1 promoter to facilitate homologous recombination in ovarian cancer. | Nat Commun | 2019 |
| 29982661 | Risk of Different Cancers Among First-degree Relatives of Pancreatic Cancer Patients: Influence of Probands' Susceptibility Gene Mutation Status. | J Natl Cancer Inst | 2019 |
| 30541042 | Agnostic Pathway/Gene Set Analysis of Genome-Wide Association Data Identifies Associations for Pancreatic Cancer. | J Natl Cancer Inst | 2019 |
| 30686551 | 53BP1 as a potential predictor of response in PARP inhibitor-treated homologous recombination-deficient ovarian cancer. | Gynecol Oncol | 2019 |
| 31015203 | Analysis of Heritability and Genetic Architecture of Pancreatic Cancer: A PanC4 Study. | Cancer Epidemiol Biomarkers Prev | 2019 |
| 31204077 | Genes associated with bowel metastases in ovarian cancer. | Gynecol Oncol | 2019 |
| 29453410 | Molecular characterization of colorectal adenomas with and without malignancy reveals distinguishing genome, transcriptome and methylome alterations. | Scientific Reports | 2018 |
| 28726808 | Prevalence of germ-line mutations in cancer genes among pancreatic cancer patients with a positive family history. | Genet Med | 2018 |
| 29491684 | Colonoscopy surveillance for high risk polyps does not always prevent colorectal cancer. | World J Gastroenterol | 2018 |
| 29422604 | Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer. | Nat Commun | 2018 |
| 29800239 | Pancreatic cancer risk is modulated by inflammatory potential of diet and ABO genotype: a consortia-based evaluation and replication study. | Carcinogenesis | 2018 |
| 29788332 | Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic Virotherapy. | J Natl Cancer Inst | 2018 |
| 28159814 | Bevacizumab May Differentially Improve Ovarian Cancer Outcome in Patients with Proliferative and Mesenchymal Molecular Subtypes. | Clin Cancer Res | 2017 |
| 28468303 | Association between Alcohol Consumption, Folate Intake, and Risk of Pancreatic Cancer: A Case-Control Study. | Nutrients | 2017 |
| 28484452 | Integration of Immune Cell Populations, mRNA-Seq, and CpG Methylation to Better Predict Humoral Immunity to Influenza Vaccination: Dependence of mRNA-Seq/CpG Methylation on Immune Cell Populations. | Front Immunol | 2017 |
| 28406492 | Time Lapse to Colorectal Cancer: Telomere Dynamics Define the Malignant Potential of Polyps. | Clin Transl Gastroenterol | 2017 |
| 28701476 | Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19-9 blood markers. | Sci Transl Med | 2017 |
| 28740577 | EGFR as a prognostic biomarker and therapeutic target in ovarian cancer: evaluation of patient cohort and literature review. | Genes Cancer | 2017 |
| 28280090 | Pooled Clustering of High-Grade Serous Ovarian Cancer Gene Expression Leads to Novel Consensus Subtypes Associated with Survival and Surgical Outcomes. | Clin Cancer Res | 2017 |